Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Century Therapeutics (IPSC) Shares Outstanding (2022 - 2025)

Century Therapeutics (IPSC) has disclosed Shares Outstanding for 4 consecutive years, with $87.5 million as the latest value for Q4 2025.

  • Quarterly Shares Outstanding rose 1.96% to $87.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $87.5 million through Dec 2025, up 1.96% year-over-year, with the annual reading at $87.5 million for FY2025, 1.96% up from the prior year.
  • Shares Outstanding for Q4 2025 was $87.5 million at Century Therapeutics, up from $86.5 million in the prior quarter.
  • The five-year high for Shares Outstanding was $87.5 million in Q4 2025, with the low at $57.6 million in Q1 2022.
  • Average Shares Outstanding over 4 years is $71.1 million, with a median of $62.6 million recorded in 2023.
  • The sharpest move saw Shares Outstanding surged 42.56% in 2024, then rose 1.96% in 2025.
  • Over 4 years, Shares Outstanding stood at $58.5 million in 2022, then rose by 3.18% to $60.3 million in 2023, then soared by 42.26% to $85.8 million in 2024, then rose by 1.96% to $87.5 million in 2025.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $87.5 million, $86.5 million, and $86.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.